Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jannik Stemler

Showing results (1-10 of 88) with videos related to

Pageof 9
Sort By:
Hemasphere|October 6, 2021
EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for MicrobiologyJannik Stemler, Ľuboš Drgoňa
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 29, 2025
The future of invasive mould infections - challenges, novelties and changing paradigmsJannik Stemler, Oliver A Cornely
Hemasphere|June 24, 2022
Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted TherapiesJannik Stemler, Oliver A Cornely
The New England Journal of Medicine|December 18, 2024
Hairy-Cell LeukemiaIlana Reinhold, Oliver A Cornely, Jannik Stemler
The Lancet. Haematology|June 30, 2022
Transparently report on the process of moving from evidence to recommendation - Authors' replyJannik Stemler, Nicole Skoetz, Oliver A Cornely
Expert Review of Vaccines|December 19, 2025
Letter to the editor: Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in GermanyJannik Stemler, Sebastian Herrmann, Oliver Cornely, et al.
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
[Infections in patients with acute myeloid leukemia]Sabine Ehrlich, Karsten Spiekermann, Jan Hendrik Grothe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2026
How to safely discontinue antifungal treatment in invasive pulmonary aspergillosis? - Clinical considerations in haematologyJannik Stemler, Rosanne Sprute, Philipp Koehler, et al.
Chemotherapy|August 11, 2025
Therapeutic drug monitoring - a driver to precision medicine for patients with hematological malignanciesJannik Stemler, Roger M Brüggemann, Nick A de Jonge
Annals of Hematology|June 10, 2020
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemmaJannik Stemler, Philipp Koehler, Christian Maurer, et al.
Pageof 9

Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Hemasphere|October 6, 2021
EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Yeast Infections: An Initiative of the European Confederation of Medical Mycology in Cooperation With the International Society for Human and Animal Mycology and American Society for MicrobiologyJannik Stemler, Ľuboš Drgoňa
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 29, 2025
The future of invasive mould infections - challenges, novelties and changing paradigmsJannik Stemler, Oliver A Cornely
Hemasphere|June 24, 2022
Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted TherapiesJannik Stemler, Oliver A Cornely
The New England Journal of Medicine|December 18, 2024
Hairy-Cell LeukemiaIlana Reinhold, Oliver A Cornely, Jannik Stemler
The Lancet. Haematology|June 30, 2022
Transparently report on the process of moving from evidence to recommendation - Authors' replyJannik Stemler, Nicole Skoetz, Oliver A Cornely
Expert Review of Vaccines|December 19, 2025
Letter to the editor: Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in GermanyJannik Stemler, Sebastian Herrmann, Oliver Cornely, et al.
Deutsche Medizinische Wochenschrift (1946)|March 29, 2023
[Infections in patients with acute myeloid leukemia]Sabine Ehrlich, Karsten Spiekermann, Jan Hendrik Grothe, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 9, 2026
How to safely discontinue antifungal treatment in invasive pulmonary aspergillosis? - Clinical considerations in haematologyJannik Stemler, Rosanne Sprute, Philipp Koehler, et al.
Chemotherapy|August 11, 2025
Therapeutic drug monitoring - a driver to precision medicine for patients with hematological malignanciesJannik Stemler, Roger M Brüggemann, Nick A de Jonge
Annals of Hematology|June 10, 2020
Antifungal prophylaxis and novel drugs in acute myeloid leukemia: the midostaurin and posaconazole dilemmaJannik Stemler, Philipp Koehler, Christian Maurer, et al.
Pageof 9